Rajiv Shrestha

Rajiv Shrestha

Boston, Massachusetts, United States
3K followers 500+ connections

About

Resilient serial entrepreneur with over a decade of experience in the fields of digital…

Articles by Rajiv

Activity

Join now to see all activity

Experience

  • QPER Health Graphic

    QPER Health

    Boston, Massachusetts, United States

  • -

    New Jersey, United States

  • -

    Boston, MA

  • -

    Greater Boston Area

  • -

    Greater Boston Area

  • -

    Gdansk, Pomeranian District, Poland

  • -

    Boston, Massachusetts, United States

  • -

    Boston

  • -

    Boston

  • -

  • -

  • -

Education

  • University of Massachusetts Amherst Graphic

    University of Massachusetts, Amherst

    -

    Dissertation title: Modeling the life span of red blood cells.

  • -

    Thesis title: A mathematical model of acute response of
    parathyroid hormone to changes in plasma ionized calcium in humans

Publications

  • Models for the Red Blood Cell Lifespan

    Journal of Pharmacokinetics and Pharmacodynamics

    The lifespan of red blood cells (RBCs) plays an important role in the study and interpretation of various clinical conditions. Yet, confusion about the meanings of fundamental terms related to cell survival and their quantification still exists in the literature. To address these issues, we started from a compartmental model of RBC populations based on an arbitrary full lifespan distribution, carefully defined the residual lifespan, current age, and excess lifespan of the RBC population, and…

    The lifespan of red blood cells (RBCs) plays an important role in the study and interpretation of various clinical conditions. Yet, confusion about the meanings of fundamental terms related to cell survival and their quantification still exists in the literature. To address these issues, we started from a compartmental model of RBC populations based on an arbitrary full lifespan distribution, carefully defined the residual lifespan, current age, and excess lifespan of the RBC population, and then derived the distributions of these parameters. For a set of residual survival data from biotin-labeled RBCs, we fit models based on Weibull, gamma, and lognormal distributions, using nonlinear mixed effects (NLME) modeling and parametric bootstrapping. From the estimated Weibull, gamma, and lognormal parameters we computed the respective population mean full lifes- pans (95% confidence interval): 115.60 (109.17-121.66), 116.71 (110.81-122.51), and 116.79 (111.23-122.75) days together with the standard deviations of the full lifespans: 24.77 (20.82-28.81), 24.30 (20.53-28.33), and 24.19 (20.43-27.73). We then estimated the 95th percentiles of the lifespan distributions (a surrogate for the maximum lifespan): 153.95 (150.02-158.36), 159.51 (155.09-164.00), and 160.40 (156.00-165.58) days, the mean current ages (or the mean residual lifespans): 60.45 (58.18-62.85), 60.82 (58.77-63.33), and 57.26 (54.33-60.61) days, and the residual half-lives: 57.97 (54.96-60.90), 58.36 (55.45-61.26), and 58.40 (55.62-61.37) days, for the Weibull, gamma, and lognormal models respectively. Corresponding estimates were obtained for the individual subjects. The three models provide equally excellent goodness-of-fit, reliable estimation, and physiologically plausible values of the directly interpretable RBC survival parameters.

    Other authors
    See publication
  • Control-Relevant Erythropoiesis Modeling in End-Stage Renal Disease

    IEEE Transactions on Biomedical Engineering

    Anemia is prevalent in end-stage renal disease (ESRD). The discovery of recombinant human erythropoietin (rHuEPO) over 30 years ago has shifted the treatment of anemia for patients on dialysis from blood transfusions to rHuEPO therapy. Many anemia management protocols (AMPs) used by clinicians comprise a set of experience-based rules for weekly-to monthly titration of rHuEPO doses based on hemoglobin (Hb) measurements. In order to facilitate the design of an AMP using model-based feedback…

    Anemia is prevalent in end-stage renal disease (ESRD). The discovery of recombinant human erythropoietin (rHuEPO) over 30 years ago has shifted the treatment of anemia for patients on dialysis from blood transfusions to rHuEPO therapy. Many anemia management protocols (AMPs) used by clinicians comprise a set of experience-based rules for weekly-to monthly titration of rHuEPO doses based on hemoglobin (Hb) measurements. In order to facilitate the design of an AMP using model-based feedback control theory, we present a physiologically-relevant erythropoiesis model and demonstrate its applicability using clinical data.

    Other authors
    See publication
  • Estimating Intravascular and Interstitial Volumes at the Start of Hemodialysis Session

    Conference: American Society of Nephrology Kidney Week 2014 Annual Meeting, At Philadelphia, PA, USA

    Intradialytic hypotension is the most common hemodialysis (HD) complication and a significant cause of morbidity. Recent models of absolute blood volume in HD patients are based on bioimpedance, tracer dilution, relative blood volume measurements or combination thereof. The goal of this study was to investigate the feasibility of estimating pre-HD intravascular and interstitial volumes using Crit-Line data during routine HD conditions. Methods: We describe fluid volume dynamics during HD using…

    Intradialytic hypotension is the most common hemodialysis (HD) complication and a significant cause of morbidity. Recent models of absolute blood volume in HD patients are based on bioimpedance, tracer dilution, relative blood volume measurements or combination thereof. The goal of this study was to investigate the feasibility of estimating pre-HD intravascular and interstitial volumes using Crit-Line data during routine HD conditions. Methods: We describe fluid volume dynamics during HD using a two-compartment model comprising intravascular and interstitial volumes. We used retrospective hematocrit (HCT) data (Crit-Line) collected every 20 seconds from 24 HD patients. Nonlinear regression was used to estimate model parameters over the initial HD period. Results: Pre-HD volumes were successfully estimated for all 24 data sets (Table1, Figure1). The mean (SD) time period required for successful estimation was 6.3 (3.4) min. The mean (SD) root
    mean square estimation error of HCT was 0.13 (0.16). Conclusions: Crit-Line HCT data can be used to estimate pre-HD intravascular and interstitial volumes in HD patients. The minimal length of data required for estimation depends on the initial refill profile driven by unknown osmotic and hydrostatic pressures. These results should be tested in a study with a larger number of patients, and validated against gold standards of absolute blood volume measurements. These results may be used to better estimate dry weight for dialysis dose prescription and red cell mass in anemia management.

    Estimating Intravascular and Interstitial Volumes at the Start of Hemodialysis Session. Available from: https://www.researchgate.net/publication/269096479_Estimating_Intravascular_and_Interstitial_Volumes_at_the_Start_of_Hemodialysis_Session [accessed Jun 9, 2015].

    Other authors
    • CH Chen
    • CV Hollot
    • J Horowitz
    • M Germain
    • Yossi ChaitC
  • A semi-mechanistic model of the time-course of release of PTH into plasma following administration of the calcytic JTT-305/MK-5442 in humans

    Journal of bone and mineral research

    JTT-305/MK-5442 is a Calcium Sensing Receptor (CaSR) allosteric antagonist being investigated for the treatment of osteoporosis. JTT-305/MK-5442 binds to CaSRs, thus preventing receptor activation by Ca2+. In the parathyroid gland, this results in the release of parathyroid hormone (PTH). Sharp spikes in PTH secretion followed by rapid returns to baseline are associated with bone formation, while sustained elevation in PTH is associated with bone resorption. We have developed a…

    JTT-305/MK-5442 is a Calcium Sensing Receptor (CaSR) allosteric antagonist being investigated for the treatment of osteoporosis. JTT-305/MK-5442 binds to CaSRs, thus preventing receptor activation by Ca2+. In the parathyroid gland, this results in the release of parathyroid hormone (PTH). Sharp spikes in PTH secretion followed by rapid returns to baseline are associated with bone formation, while sustained elevation in PTH is associated with bone resorption. We have developed a semi-mechanistic, non-population model of the time-course relationship between JTT-305/MK-5442 and whole plasma PTH concentrations to describe both the secretion of PTH and the kinetics of its return to baseline levels. We obtained mean concentration data for JTT-305/MK-5442 and whole PTH from a multiple dose study in US postmenopausal women at doses of 5, 10, 15 and 20 mg. We hypothesized that PTH is released from two separate sources: a reservoir that is released rapidly (within minutes) in response to reduction in Ca2+ binding, and a second source released more slowly following hours of reduced Ca2+ binding. We modeled the release rates of these reservoirs as Emax functions of JTT-305/MK-5442 concentration. Our model describes both the dose-dependence of PTH Tmax and Cmax, and the extent and duration of the observed non-monotonic return of PTH to baseline levels following JTT-305/MK-5442 administration.

    Other authors
    • Antonio Cabal
    • Khamir Mehta
    • David S. Ross
    • Wendy Comisar
    • Andrew Denker
    • Sudhakar M. Pai
    • Tomohiro Ishikawa
    See publication
  • Book Title: Issues in Dialysis; Chapter 14: Update on Anemia and kidney disease

    Nova publishers

    Book Description:
    Despite our efforts at creating clinical performance measures, clinical practice guidelines and intense government regulations, we still have disparities in care, poor outcomes and quality that is inferior to many other nations. Bundling and payment reform challenge the ability to deliver good care to patients even further. Chronic dialysis is at a crossroads. Physicians and providers must incorporate new approaches, reinventing the paradigm of how to plot the course of…

    Book Description:
    Despite our efforts at creating clinical performance measures, clinical practice guidelines and intense government regulations, we still have disparities in care, poor outcomes and quality that is inferior to many other nations. Bundling and payment reform challenge the ability to deliver good care to patients even further. Chronic dialysis is at a crossroads. Physicians and providers must incorporate new approaches, reinventing the paradigm of how to plot the course of patient therapy. This book offers new ideas. It is refreshing, timely and engaging, with a wide range of topics by leading authors, each designed to help meet the challenges yet to come.

    Other authors
    • KM Goli
    • A Pinkersov
    • DL Landry
    • Y Chait
    • J Horowitz
    • CV Hollot
    • MJ Shrestha
    See publication
  • Simplification of an Erythropoiesis Model for Design of Anemia Management Protocols in End Stage Renal Disease

    Conf Proc IEEE Eng Med Biol Soc.

    Abstract
    Many end stage renal disease (ESRD) patients suffer from anemia due to insufficient endogenous production of erythropoietin (EPO). The discovery of recombinant human EPO (rHuEPO) over 30 years ago has shifted the treatment of anemia for patients on dialysis from blood transfusions to rHuEPO therapy. Many anemia management protocols (AMPs) used by clinicians comprise a set of experience-based rules for weekly-to-monthly titration of rHuEPO doses based on hemoglobin (Hgb)…

    Abstract
    Many end stage renal disease (ESRD) patients suffer from anemia due to insufficient endogenous production of erythropoietin (EPO). The discovery of recombinant human EPO (rHuEPO) over 30 years ago has shifted the treatment of anemia for patients on dialysis from blood transfusions to rHuEPO therapy. Many anemia management protocols (AMPs) used by clinicians comprise a set of experience-based rules for weekly-to-monthly titration of rHuEPO doses based on hemoglobin (Hgb) measurements. In order to facilitate the design of an AMP based on formal control design methods, we present a physiologically-relevant erythropoiesis model, and show that its nonlinear dynamics can be approximated using a static nonlinearity, a step that greatly simplifies AMP design. We demonstrate applicability of our results using clinical data.

    Other authors
    See publication
  • A Mathematical Model of Parathyroid Hormone Response to Changes in Plasma Ionized Calcium Concentration in Humans

    Mathematical Biosciences

    A complex bio-mechanism, commonly referred to as calcium homeostasis, regulates plasma ionized calcium (Ca2+) concentration in the human body within a narrow range which is crucial for maintaining normal physiology and metabolism. Taking a step towards creating a complete mathematical model of calcium homeostasis, we focus on the short-term dynamics of calcium homeostasis and consider the response of the parathyroid glands to acute changes in plasma Ca2+ concentration. We review available…

    A complex bio-mechanism, commonly referred to as calcium homeostasis, regulates plasma ionized calcium (Ca2+) concentration in the human body within a narrow range which is crucial for maintaining normal physiology and metabolism. Taking a step towards creating a complete mathematical model of calcium homeostasis, we focus on the short-term dynamics of calcium homeostasis and consider the response of the parathyroid glands to acute changes in plasma Ca2+ concentration. We review available models, discuss their limitations, then present a two-pool, linear, time-varying model to describe the dynamics of this calcium homeostasis subsystem, the Ca–PTH axis. We propose that plasma PTH concentration and plasma Ca2+ concentration bear an asymmetric reverse sigmoid relation. The parameters of our model are successfully estimated based on clinical data corresponding to three healthy subjects that have undergone induced hypocalcemic clamp tests. In the first validation of this kind, with parameters estimated separately for each subject we test the model’s ability to predict the same subject’s induced hypercalcemic clamp test responses. Our results demonstrate that a two-pool, linear, time-varying model
    with an asymmetric reverse sigmoid relation characterizes the short-term dynamics of the Ca–PTH axis.

    Other authors
    • Christopher V. Hollot
    • Stuart R. Chipkin
    • Claus P. Schmitt
    • Yossi Chait
    See publication

Projects

  • A model of HbA1c response to changes in Fasting Plasma Glucose (FPG) due to a drug in diabetes patients

    -

    As a postdoc I built and validated a predictive mathematical model of HbA1c response to Merck's diabetes drug under development using their clinical trial data from various stages of development. Initial model was built on MATLAB. The final model was built and validated using NONMEM.

Languages

  • Nepali, Newari,

    -

More activity by Rajiv

View Rajiv’s full profile

  • See who you know in common
  • Get introduced
  • Contact Rajiv directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Rajiv Shrestha in United States

Add new skills with these courses